Physician

Kristin Molly Liptock, DO

According to 2025 Medicare claims, Kristin Liptock, DO (NPI: 1407064181) practices hematology/oncology in the Scranton--Wilkes-Barre, PA market, with the plurality of this provider's patient population coming from Lackawanna, PA. This provider's primary affiliated billing organization is HEMATOLOGY AND ONCOLOGY ASSOCIATES OF NORTHEASTERN PA, PC (NPI: 1164538724; TIN: 232137083) and primary practice location at 18512-3169. Liptock is affiliated with the Keystone ACO (ACO ID: A1552), participating under the MSSP model.

Liptock's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 868 traditional Medicare patients, billed 106,103 HCPCS/CPT codes, and received $1,673,568 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,256 prescription claims across 214 beneficiaries totaling $3,521,661 in drug costs, led by Calquence (Acalabrutinib Maleate). DME data shows 43 claims. Open Payments data shows 5 records totaling $159. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $1,599,197 and ending at $1,673,568. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $876,394 to $3,521,661. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	692	128,620	$1,599,197
2016	681	172,755	$1,826,744
2017	633	111,731	$1,015,752
2018	676	141,470	$2,639,210
2019	721	113,905	$1,671,824
2020	730	110,050	$1,650,110
2021	765	141,535	$1,690,215
2022	872	137,745	$1,574,714
2023	867	124,448	$1,950,189
2024	868	106,103	$1,673,568

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	194	998	$876,394
2016	158	935	$829,821
2017	153	829	$1,030,847
2018	162	950	$1,204,343
2019	172	858	$1,051,014
2020	159	909	$1,447,639
2021	185	1,071	$2,163,836
2022	209	1,093	$2,978,725
2023	214	1,119	$2,880,848
2024	214	1,256	$3,521,661

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	150	$43,607
2016	11	186	$46,154
2017	N/R	104	$19,054
2018	12	137	$14,654
2019	N/R	67	$7,887
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	53	$17,241
2024	N/R	43	$1,036

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	369	761	$90
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	465	635	$59
80053	Blood test, comprehensive group of blood chemicals	731	1,740	$10
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	731	2,012	$8
83540	Iron level	328	588	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Calquence	Acalabrutinib Maleate	45	1,350	$665,081
Ibrance	Palbociclib	41	1,148	$611,313
Lenalidomide	Lenalidomide	24	672	$376,718
Revlimid	Lenalidomide	11	308	$252,800
Promacta	Eltrombopag Olamine	12	360	$153,892

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	22	$678
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	21	$358

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$159	SOBI, INC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kristin Molly Liptock, DO?

Tedicare shows public-source Medicare data for Kristin Molly Liptock, DO (NPI 1407064181), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kristin Molly Liptock, DO have ACO affiliation data?

Kristin Molly Liptock, DO is shown with ACO affiliation data for Keystone ACO (MSSP, ACO ID A1552).

What billing organization is linked to Kristin Molly Liptock, DO?

Kristin Molly Liptock, DO is linked to HEMATOLOGY AND ONCOLOGY ASSOCIATES OF NORTHEASTERN PA, PC (billing NPI 1164538724) in the available physician profile data.

Does Kristin Molly Liptock, DO have Open Payments data?

Kristin Molly Liptock, DO has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.